Relay Therapeutics acquires AI startup for $85M

Relay Therapeutics, the Cambridge precision medicine company that raced onto the stock market last summer with one of the largest IPOs in the biotech industry, is looking to build out its data science capabilities.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.